Home > Insider Trading > Filing (0001104659-19-036445)

Filing Details

Accession Number:: 0001104659-19-036445
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-19 19:22:43
Reporting Period:: 2019-06-17

Accepted Time:: 2019-06-19 19:22:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1192448	Glaukos Corp	GKOS	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705850	E Joseph Gilliam	C/O Glaukos Corporation, 229 Avenida Fabricante San Clemente CA 92672	Cfo, Svp Corporate Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-06-17	6,250	$41.69	53,313	No	4	M	Direct
Common Stock	Disposition	2019-06-17	4,292	$73.95	49,021	No	4	S	Direct
Common Stock	Disposition	2019-06-17	1,958	$74.80	47,063	No	4	S	Direct
Common Stock	Acquisiton	2019-06-17	2,500	$30.92	49,563	No	4	M	Direct
Common Stock	Disposition	2019-06-17	1,784	$73.97	47,779	No	4	S	Direct
Common Stock	Disposition	2019-06-17	716	$74.82	47,063	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2019-06-17	6,250	$0.00	6,250	$41.69
Common Stock	Stock Options (Right to Buy)	Disposition	2019-06-17	2,500	$0.00	2,500	$30.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
175,593		2027-05-05	No	4	M	Direct
50,545		2028-03-14	No	4	M	Direct

Footnotes

Includes 37,853 restricted stock units that have not yet vested or been delivered to the Reporting Person.
These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This transaction was executed in multiple trades at prices ranging from $73.49 to $74.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $74.49 to $75.255. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $73.57 to $74.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $74.57 to $75.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.